glp 1 conference 2025 GLP-1s and the Future of Workforce How GLP-1s Are Showing Up

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

Adipokines (e.g., leptin and adiponectin) are regulated by DPP-4 and may influence bone remodeling and energy metabolism in a paracrine manner

They produce weight loss unlike anything we've seen before, and the more we study them, the longer the list of things they seem to hel

The CareCredit pharmacy network has nationwide locations making it easier to pay for prescriptions and other health-related products and services.

An active-comparator new user study design was used to minimise risks of confounding and time related biases from using real world studies of drug effects